Febrile cover image

74: 2 Fast 2 Feverish: Late ID Complications of CAR-T therapy

Febrile

00:00

Cloit Infections After CD19 CAR-T

IgG levels reached their nadir at 6 months, and then about half of the patients did not need immunoglobulin replacement therapy. Another study of 41 patients with large B-cell lymphoma who also got the access out, 10% had hypogamagma prior to lymphodifluition. It seems that lower rates have been reported with other CD19 products.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app